Micronised Fenofibrate: An Updated Review of its Clinical Efficacy in the Management of Dyslipidaemia

By Keating G.M.   Ormrod D.  

Drugs, Vol. 62, Iss. 13, 2002-01 ,pp. : 1909-1944

Adis International

Access to resources Recommend Favorite

Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia

By Kiortsis D.N.   Millionis H.   Bairaktari E.   Elisaf M.S.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 631-635

Springer Publishing Company

Access to resources Recommend Favorite

Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia

By Filippatos Theodosios D   Elisaf Moses S  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1945-1958

Informa Healthcare

Access to resources Recommend Favorite

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study

By Florentin M   Liberopoulos EN   Filippatos TD   Kostara C   Tselepis A   Mikhailidis DP   Elisaf M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2741-2750

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy

By González Carlos A.   Rubio-Guerra Alberto F.   Pavía Abel   Redding Francisco J.   Cervantes José L.   Zacarías José L.   Yza Rubén   Carranza Jaime   Fernández Pedro   Morales Enrique   Robles Francisco J.   Leyva José L.   Rodríguez Leticia  

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 333-337

Adis International

Access to resources Recommend Favorite